Disclosure Panels Details Page
Wilms Tumor Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Clarke Anderson MD | None | None | None | None | 08/28/2022 |
| Amy Armstrong MD | None | None | Bionest EM Partners |
None | 09/28/2022 |
| Jamie Aye MD | None | None | None | None | 05/14/2023 |
| Frank Balis MD | Day One Pharmaceuticals Eli Lilly and Company |
None | None | None | 02/28/2023 |
| Daniel Benedetti MA,MD | None | None | None | None | 04/06/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Brandon Brown MD,BS | None | None | None | None | 12/28/2022 |
| Erin Brown MD | None | None | None | None | 05/12/2023 |
| Shelly Cook MD | None | None | None | None | 05/30/2022 |
| Jasreman Dhillon MD | None | None | None | None | 01/10/2023 |
| Mary Dwyer MS | None | None | None | None | 05/11/2023 |
| Douglas Fair MS,MD | None | None | None | None | 02/27/2023 |
| Daniel Geynisman MD | None | Bristol-Myers Squibb Company Exelixis Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. |
None | None | 01/03/2023 |
| Kenneth Gow MD,MHA | None | None | None | None | 02/08/2023 |
| Daniel Green MD | None | None | None | None | 01/24/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Susan Hiniker MD | None | None | None | None | 02/24/2023 |
| Miranda Hughes PhD | None | None | None | None | 01/16/2023 |
| Rama Jasty-Rao MD | None | None | None | None | 04/23/2023 |
| Marissa Just MD | None | None | None | None | 10/02/2022 |
| Chi Lin PhD,MD | BioMimelix JV, LLC | None | None | None | 04/25/2023 |
| Senem Lubin PhD,MBA | None | None | None | None | 02/02/2023 |
| Daniel Lui PharmD,BCPPS | None | None | None | None | 05/15/2023 |
| Iain MacEwan MD | None | None | None | None | 02/17/2023 |
| Julian Martinez–Agosto PhD,MD,FABMG | None | None | None | None | 04/03/2023 |
| Nicole McMillian MS | None | None | None | None | 05/23/2023 |
| Sarah Montgomery | None | None | None | None | 03/22/2023 |
| Elizabeth Mullen MD | Childrens Oncology Group I am on international data safety monitoring board for Randomet2017 EudraCT-No.: 2018-000533-13 Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV child-hood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standard a |
I am on SAB for Camp Casco, camp for children with cancer | None | None | 02/25/2023 |
| Erin Murphy MD | None | None | None | None | 09/27/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Mark Ranalli MD | None | None | None | None | 03/17/2023 |
| Daniel Rhee MD,FACS,MPH | None | None | None | None | 12/19/2022 |
| Denise Rokitka MD,MPH | None | None | None | None | 09/28/2022 |
| Samantha Tamburro CPON,RN,BSN | None | None | Flatiron Health, Inc. | None | 05/19/2023 |
| Elisabeth (Lisa) Tracy MD | None | None | None | None | 12/05/2021 |
| Tamara Vern-Gross DO | None | None | None | None | 08/08/2022 |
| Michael Walsh MD | None | None | None | None | 10/03/2022 |
| Amy Walz MD | None | None | None | None | 12/13/2022 |
| Jonathan Wickiser MD | None | None | None | None | 02/20/2023 |
| Matthew Zapala PhD,MD | None | None | None | None | 03/13/2023 |